TXA2 synthesis and COX1-independent platelet reactivity in aspirin-treated patients soon after acute cerebral stroke or transient ischaemic attack.
Autores de IIS La Fe
Grupos
Abstract
The pharmacological target of aspirin is the inhibition of cyclooxygenase-1 (COX1) and thromboxane-A2 (TX) synthesis. Very few data are available on TX assessment in patients with stroke. We studied platelet TX synthesis, COX1-independent platelet reactivity, the influence of platelet-erythrocyte interactions and the potential association between platelet responses and the severity of stroke, evaluated with a clinical score (NIHSS).
Datos de la publicación
- ISSN/ISSNe:
- 0049-3848, 1879-2472
- Tipo:
- Article
- Páginas:
- 211-216
- PubMed:
- 23830213
- Factor de Impacto:
- 1,050 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
THROMBOSIS RESEARCH PERGAMON-ELSEVIER SCIENCE LTD
Citas Recibidas en Web of Science: 10
Documentos
- No hay documentos
Filiaciones
Keywords
- Acute stroke, Aspirin, Cyclooxygenase-1, Platelet–erythrocyte interactions, Thromboxane A(2)
Campos de Estudio
Cita
VALLES J,LAGO A,MOSCARDO A,TEMBL J,PARKHUTIK V,SANTOS MT. TXA2 synthesis and COX1-independent platelet reactivity in aspirin-treated patients soon after acute cerebral stroke or transient ischaemic attack. Thromb. Res. 2013. 132. (2):p. 211-216. IF:2,427. (3).
Portal de investigación